Vaginal Microbiota and Its Association with Pap Smear Results, Human Papillomavirus, Vitamins, and Metabolic Mark
Launched by CHENG-HSIN GENERAL HOSPITAL · Mar 26, 2025
Trial Information
Current as of April 23, 2025
Completed
Keywords
ClinConnect Summary
Vaginal Microbiome, pH, Menopause, and Metabolic Factors
The human body is colonized by a vast array of symbiotic, commensal, and pathogenic microorganisms, including bacteria, fungi, and viruses. The relationship between these microorganisms and the host varies from mutualistic and commensal to pathogenic interactions, collectively referred to as the microbiome. The human microbiome resides on both external and internal surfaces of the body, playing a critical role in physiology, immune system development, digestion, and detoxification. The metagenome of bacterial populations within the h...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participants must meet all of the inclusion criteria
- • Female participants
- • History of sexual activity
- • Age 30 years or older
- Exclusion Criteria:
- * Participants will be excluded from the study if they meet any of the following conditions:
- • Currently pregnant at the time of enrollment or before sample collection day.
- • History of total hysterectomy.
About Cheng Hsin General Hospital
Cheng-Hsin General Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust framework for conducting research, the hospital fosters collaboration among multidisciplinary teams to explore new therapeutic options and enhance clinical practices. By leveraging state-of-the-art facilities and a patient-centered approach, Cheng-Hsin General Hospital aims to contribute significantly to the medical community and drive forward the development of effective treatments across various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported